News
4d Pharma PLC - Updated Results from Renal Cell Carcinoma Cohort
RNS Number: 7844 O 4 d Pharma PLC 02 February 2023 4 D pharma plc. 4 D pharma Announces Updated Results from the Renal Cell Carcinoma Cohort of the Phase I/II Study of the Combination of MRx0518 and KEYTRUDA ®. Leeds, UK, February 2, 2023- 4 D pharma plc, a pharmaceutical company leading the development of Live Biotherapeutic products, a novel class of drug derived from...
sup{font-size:80%}p{margin-right:0cm;margin-left:0cm;font-size:12.0pt;font-family:"Times New Roman","serif";}ol{margin-bottom:0cm;}ul{margin-bottom:0cm;}link{ color: #0563C1 }visited{ color: #954F72 } .ae{size:612.0pt 792.0pt;margin:72.0pt 72.0pt ...